• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白Bart's病胎儿与非贫血胎儿心肌肌钙蛋白T和N末端B型利钠肽原的比较。

Comparison of cardiac troponin T and N-terminal pro-B-type natriuretic peptide between fetuses with hemoglobin Bart's disease and nonanemic fetuses.

作者信息

Tongprasert Fuanglada, Srisupundit Kasemsri, Luewan Suchaya, Tongsong Theera

机构信息

Maternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

Prenat Diagn. 2014 Sep;34(9):864-9. doi: 10.1002/pd.4384. Epub 2014 Apr 30.

DOI:10.1002/pd.4384
PMID:24733401
Abstract

OBJECTIVE

The objective of this study was to compare the levels of fetal serum cardiac troponin T (cTnT), representing cardiac injury, and N-terminal pro-B-type natriuretic peptide (nt-proBNP), representing cardiac volume overload, between fetuses affected and not affected by hemoglobin (Hb) Bart's disease, as well as between anemic and nonanemic fetuses.

METHODS

One hundred fourteen pregnancies at risk for fetal Hb Bart's disease scheduled for cordocentesis at 18 to 22 weeks were recruited into the study. Fetal blood was collected to test for cTnT, nt-proBNP and Hb levels as well as Hb typing.

RESULTS

Serum nt-proBNP was significantly higher in Hb Bart's fetuses (24 cases) than in unaffected fetuses (63 cases), whereas cTnT was significantly lower in the affected group than in the unaffected group. The serum nt-proBNP levels significantly increased with the degree of fetal anemia; cTnT levels decreased in fetuses with high degree of anemia.

CONCLUSIONS

At mid-pregnancy, nt-proBNP was significantly higher in fetuses with Hb Bart's disease than in nonanemic fetuses; cTnT was significantly lower in anemic than in normal fetuses. This study suggests that cardiomegaly from fetal anemia in early gestation is not associated with fetal cardiac injury or myocardial dysfunction but presents as cardiac volume overload from a compensatory process to maintain adequate tissue oxygenation.

摘要

目的

本研究的目的是比较受血红蛋白(Hb)Bart病影响和未受影响的胎儿之间,以及贫血和非贫血胎儿之间,代表心脏损伤的胎儿血清心肌肌钙蛋白T(cTnT)水平和代表心脏容量超负荷的N末端B型利钠肽原(nt-proBNP)水平。

方法

招募了114例计划在18至22周进行脐带穿刺术的有胎儿Hb Bart病风险的孕妇进入研究。采集胎儿血液以检测cTnT、nt-proBNP和Hb水平以及Hb分型。

结果

Hb Bart病胎儿(24例)的血清nt-proBNP显著高于未受影响的胎儿(63例),而受影响组的cTnT显著低于未受影响组。血清nt-proBNP水平随胎儿贫血程度显著升高;高度贫血胎儿的cTnT水平降低。

结论

在妊娠中期,患有Hb Bart病的胎儿的nt-proBNP显著高于非贫血胎儿;贫血胎儿的cTnT显著低于正常胎儿。本研究表明,妊娠早期胎儿贫血引起的心脏肥大与胎儿心脏损伤或心肌功能障碍无关,而是表现为一种代偿过程导致的心脏容量超负荷,以维持足够的组织氧合。

相似文献

1
Comparison of cardiac troponin T and N-terminal pro-B-type natriuretic peptide between fetuses with hemoglobin Bart's disease and nonanemic fetuses.血红蛋白Bart's病胎儿与非贫血胎儿心肌肌钙蛋白T和N末端B型利钠肽原的比较。
Prenat Diagn. 2014 Sep;34(9):864-9. doi: 10.1002/pd.4384. Epub 2014 Apr 30.
2
Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.孕中期血红蛋白Bart's病所致胎儿贫血孕妇血清抑制素A水平研究
J Matern Fetal Neonatal Med. 2014 Jul;27(10):1005-9. doi: 10.3109/14767058.2013.852532. Epub 2013 Nov 7.
3
Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.孕中期正常胎儿、α-地中海贫血1特征胎儿和血红蛋白Bart胎儿的红细胞血液学比较。
Am J Hematol. 2008 Dec;83(12):908-10. doi: 10.1002/ajh.21287.
4
Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.比较伴有和不伴有胎儿血红蛋白 Bart's 病的孕妇血清 PlGF 和 sFlt-1。
Prenat Diagn. 2013 Dec;33(13):1272-5. doi: 10.1002/pd.4246. Epub 2013 Oct 22.
5
Maternal serum hCG, PAPP-A and AFP as predictors of hemoglobin Bart disease at mid-pregnancy.母血清 hCG、PAPP-A 和 AFP 作为中孕期血红蛋白 Bart 病的预测指标。
Prenat Diagn. 2011 May;31(5):430-3. doi: 10.1002/pd.2705. Epub 2011 Feb 10.
6
Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.孕中期母体血清标志物及预测胎儿血红蛋白Bart病的预测模型。
J Matern Fetal Neonatal Med. 2013 Jan;26(2):146-9. doi: 10.3109/14767058.2012.730583. Epub 2012 Oct 10.
7
Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment.胎儿血红蛋白巴氏水肿胎儿:病理生理学、产前诊断及宫内治疗的可能性
J Matern Fetal Neonatal Med. 2018 Apr;31(7):946-957. doi: 10.1080/14767058.2017.1301423. Epub 2017 Mar 21.
8
Fetal hemodynamic changes and mitochondrial dysfunction in myocardium and brain tissues in response to anemia: a lesson from hemoglobin Bart's disease.针对贫血时心肌和脑组织中胎儿血液动力学变化和线粒体功能障碍:来自血红蛋白 Bart 病的启示。
BMC Pregnancy Childbirth. 2024 Feb 16;24(1):141. doi: 10.1186/s12884-023-06232-x.
9
The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.术前贫血与N端前脑钠肽之间的相互关系:对血管外科手术患者术后心脏结局预测的影响。
Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.
10
Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.孕中期利用胎儿心脏直径与双顶径比值对有风险的胎儿进行血红蛋白Bart's病筛查。
BMC Pregnancy Childbirth. 2014 Jul 16;14:230. doi: 10.1186/1471-2393-14-230.

引用本文的文献

1
Placenta-Derived Extracellular Vesicles in Pregnancy Complications and Prospects on a Liquid Biopsy for Hemoglobin Bart's Disease.胎盘来源的细胞外囊泡与妊娠并发症及血红蛋白 Bart's 病液体活检的展望
Int J Mol Sci. 2023 Mar 16;24(6):5658. doi: 10.3390/ijms24065658.
2
Comparisons of serum non-transferrin-bound iron levels and fetal cardiac function between fetuses affected with hemoglobin Bart's disease and normal fetuses.患有血红蛋白Bart's病的胎儿与正常胎儿血清非转铁蛋白结合铁水平及胎儿心功能的比较。
Front Med (Lausanne). 2023 Jan 3;9:1015306. doi: 10.3389/fmed.2022.1015306. eCollection 2022.
3
The Association between N-terminal Pro-Brain Natriuretic Peptide Levels in the Umbilical Vein and Amniotic Fluid Volume Abnormalities.
脐静脉中N末端脑钠肽前体水平与羊水量异常之间的关联
Rev Bras Ginecol Obstet. 2016 Apr;38(4):177-82. doi: 10.1055/s-0036-1583172. Epub 2016 Apr 20.